Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroendocrine Tumors 7Neoplasms 6Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoid Tumor 5Stomach Neoplasms 4Esophageal Neoplasms 4Acromegaly 4Weight Loss 3Rectal Neoplasms 3Pancreatic Neoplasms 3Diarrhea 3Carcinoma 3Breast Neoplasms 3Vipoma 2Thymoma 2Somatostatinoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Insulinoma 2Glucagonoma 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Adenoma, Islet Cell 2Zollinger-Ellison Syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma × Octreotide × Clear all
NCT00002779 2016-12-15

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
34 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡